NAs
Sponsors
The Second Affiliated Hospital of Chongqing Medical University, Samsun University, Beijing 302 Hospital, Ausper Biopharma Co., Ltd., Xiamen Humanity Hospital
Conditions
Anti-PD-1 AntibodyChronic Hepatitis BChronic Hepatitis bHBV-related Liver CirrhosisNurse's RolePeg-IFNα
Phase 2
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
RecruitingNCT05769816
Start: 2023-10-10End: 2026-12-31Target: 120Updated: 2025-09-11
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
RecruitingNCT05771402
Start: 2023-10-10End: 2026-12-31Target: 120Updated: 2025-09-11
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
Active, not recruitingNCT06829329
Start: 2024-12-13End: 2025-11-30Updated: 2025-09-24
Unknown Phase
Nursing Activity Score (Nursing Activities Score-NAS) Verification of Turkish Version
CompletedNCT06206889
Start: 2023-05-05End: 2023-11-12Updated: 2024-01-16
The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients
Active, not recruitingNCT06357806
Start: 2024-05-17End: 2026-10-08Target: 45Updated: 2026-03-18
Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients
RecruitingNCT06457477
Start: 2024-06-15End: 2025-12-15Target: 50Updated: 2024-06-20
A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis
Not yet recruitingNCT07183293
Start: 2025-10-31End: 2031-09-30Target: 30Updated: 2025-09-19